ArticleHeliyon2023

An online clinical model and risk stratification system to predict progression-free survival for advanced non-small-cell lung cancer patients treated with PD-(L)1 inhibitor.

Zegui Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.